Skip to main content
WW logo

WW · Ww International, Inc.

Track WW — free
$17.09 +0.82 (+5.04%) At close · Sep 2
Market Cap
$172.23M
Shares
10.00M

WW metrics

51 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$17.09
Market cap
$172.23M

Price action

19 metrics
Price change (1W)
-7.8%
Price change (30D)
+1.2%
Price change (3M)
+1.8%
Price change (6M)
-25.3%
Price change (YTD)
-44.3%
Price change (1Y)
-49.0%
Trailing year
Price change (5Y)
52-week high
$34.92
52-week low
$9.12
Change from 52-week high
-53.4%
Change from 52-week low
+78.4%
Annualized volatility
91.4%
Beta
2.4
RSI (14D)
53.6
Price vs SMA 50
+5.4%
Price vs SMA 200
-12.8%
Avg volume (3M)
188,301
Relative volume
0.8
Average dollar volume
$3.07M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
10.00M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
0.2×
reciprocal yield 457.0%
P / book
0.6
reciprocal yield 171.9%
FCF yield
TTM · current market cap
Buyback yield
0.0%
P / FCF
P / operating cash flow
Earnings yield

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
0.0%
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
67.8%
Operating margin
-30.1%
Trailing 12 months
Net margin
-44.0%
Gross profit (TTM)
Operating profit (TTM)
Net income (TTM)
Trailing 12 months
Diluted EPS (TTM)
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share

Growth

11 metrics
Revenue growth YoY
+1,234.1%
Year over year
Net income growth YoY
+1,022.3%
Revenue (TTM)
$740.87M
Trailing 12 months
EPS growth YoY
+984.6%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
-13.4%
Revenue CAGR (5Y)
-11.1%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
332.0%
Return on assets
111.5%
Debt / equity
Current ratio
1.4
EBITDA (TTM)
Free cash flow (TTM)
Quick ratio
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$101.50M
Total assets
$840.44M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
Capital expenditures (TTM)
R&D (TTM)
SG&A (TTM)
Stock compensation (TTM)
R&D / revenue
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
78
13F filer change QoQ
-6
Institutional ownership
75.3%

Short interest

3 metrics
Short interest
16.6%
Latest settlement · 6.3 days to cover
Days to cover
6.3d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
$100,132
Insider-sentiment score
81 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 105319 CUSIP 98262P200 13F (30d) 65 filings 63 filers Visit website Investor relations